WESTBROOK, Maine, March 20, 2017 /PRNewswire/ -- IDEXX
Laboratories, Inc. (Nasdaq: IDXX) announced that it joined the
NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal
Weighted Index (Nasdaq: NDXE), and the NASDAQ-100 Ex Technology
Index (Nasdaq: NDXX) prior to market open today.
"We're very pleased that IDEXX is included in the NASDAQ-100
Index, alongside an impressive group of growth-oriented, domestic
and international companies, who are innovators of the modern
economy," said Jonathan Ayers,
Chairman and Chief Executive Officer of IDEXX Laboratories.
"Following our inclusion in the S&P 500 earlier this year,
becoming a part of the NASDAQ-100 is further acknowledgment of the
tremendous growth our company has achieved through innovation
focused on pet healthcare technology."
Launched in January 1985, the
NASDAQ-100 Index (NDX) includes many category-defining companies
that are on the forefront of innovation in their respective
industries, and represents the largest non-financial domestic and
international securities listed on The Nasdaq Stock Market based on
market capitalization. Since its inception, NDX has become the
world's preeminent large-cap growth index, with the aggregate
market capitalization of the component companies standing at over
$6 trillion and more than
$50 billion of investments in
exchange traded products tied to the index.
For more IDEXX corporate information, visit:
www.idexx.com/investors
About IDEXX Laboratories
IDEXX Laboratories,
Inc. is a member of the S&P 500® Index and is a
leader in pet healthcare innovation, serving practicing
veterinarians around the world with a broad range of diagnostic and
information technology-based products and services. IDEXX products
enhance the ability of veterinarians to provide advanced medical
care, improve staff efficiency, and build more economically
successful practices. IDEXX is also a worldwide leader in providing
livestock and poultry diagnostic tests and tests for the quality
and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people
and offers products to customers in over 175 countries. For more
information about IDEXX, visit: www.idexx.com.
Contact:
Investor Relations:
Kerry
Bennett
1-207-556-8155
Media:
Robin Woodcock
1-617-429-6153
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/idexx-laboratories-joins-the-nasdaq-100-index-300425641.html
SOURCE IDEXX Laboratories, Inc.